|Articles|July 15, 2013

Pharmaceutical Technology

  • Pharmaceutical Technology-07-15-2013
  • Volume 2013 eBook
  • Issue 1

Impurity Profiling Using Convergence Chromatography and Mass Spectrometry

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling.

 

Coupling ultra-performance convergence chromatography to mass spectrometry provides an important tool for pharmaceutical analysis.

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling. This was achieved by using metoclopramide and its related substances and metoclopramide drug products as examples.

View 

Pharmaceutical Technology’s 2013 Analytical and Bioanalytical Testing ebook

.

 

 

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.